# Top 50 Medical Device VC (Venture Capital) Funds in Australia in June 2026

## Brandon Capital
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 8
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Health Care

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 6
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Uniseed
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Manufacturing

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ).  This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities.  Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund.   The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation).  Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets.  It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide.  They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes.  Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Energy

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Seed, Angel, Pre-Seed
- Focus: Software, SaaS, Health Care

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## Breakthrough Victoria
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Manufacturing, Biotechnology

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

## Significant Ventures
- Type: VC Fund
- Location: Canberra, Australian Capital Territory, Australia
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Manufacturing, Software, Health Care

Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy

## South Australian Venture Capital Fund
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Health Care, Biotechnology, Internet of Things

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

## Global Health Investment Fund (GHIF)
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical Device

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Manufacturing

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Regal Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Convertible Note, Series B
- Focus: Software, Financial Services, FinTech

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

## Avicella Capital
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Therapeutics, Medical, Robotics

Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.

## Terra Rossa Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

## CoAct Capital
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, Information Technology, SaaS

Co:Act is an investment partnership of experienced venture investors with a network of founders.

## OneVentures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Software, Health Care, Biotechnology

OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

## PsyMed Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical

We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.

## Blackbird Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, SaaS

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

## Powerhouse Ventures
- Type: VC Fund
- Location: Oakland, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Energy, Solar

Powerhouse Ventures
backs entrepreneurs building the digital infrastructure for rapid decarbonization.

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Software, Health Care

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## Brisbane Angels
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: Software, Biotechnology, Machine Learning

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

## Ramsay Health Care
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Medical Device

Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.

## Venture-Store Pty Ltd
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Seed
- Focus: Wellness, Blockchain, Health Care

Only a few year ago, it took $ millions to get a tech venture to market; $1m before cutting a line of code, another $1m or so to get v1.0 into customers hands, millions more refining it.​That was for a start up. Multiply it times over for a large corporate.Then, assuming it was a product people used/wanted, millions to scale it. If theproduct/market fit wasn't there, millions more to pivot, chase a business model.​Today ideas can be conceived, tested, architected, teams added, capabilities assembled, services built, deployed, at scale, globally for a fraction of the cost and time.Venture-Store is founded upon this profound shift: ideas with unicorn scale, potential, shipped to market rapidly, inexpensively, by anyone from anywhere in the world.The scale, sophistication and configurability of tech is fuelling unprecedented innovation throughout business and society. Markets are up for grabs, open to new, better ways of solving problems and creating value for consumers. For entrepreneurs, start ups, corporations and investors the game is changing. Earlier access to new ventures is more important than ever to investment returns.

## SFC Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Pre-Seed, Seed
- Focus: Software, Artificial Intelligence, Information Technology

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## Anova Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Education, Rental, Travel

Anova Capital focus on investment in education, big health and new consumption.

## Upswell Ventures
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Developer Tools, Apps

We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.

## Development Bank of Wales
- Type: VC Fund
- Location: Cardiff, Cardiff, United Kingdom
- Relevant deals: 1
- Stages: Seed, Debt Financing
- Focus: Software, Health Care, Biotechnology

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

## HealthCare Ventures
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

## Playford Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

## CP Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Artificial Intelligence, Machine Learning

The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.

## Grand Challenges Canada
- Type: VC Fund
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Grant, Seed, Debt Financing
- Focus: Health Care, Medical Device, Biotechnology

Learn how we find, fund and support high-impact innovations

## BridgeLane Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Real Estate, Financial Services

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

## Archangel Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, SaaS, Artificial Intelligence

Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.

## Sirius Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 1
- Stages: Series A, Seed, Angel
- Focus: Artificial Intelligence, Robotics, Video

Sirius Capital is a venture capital firm in China that invests in technology companies.

## Victoria University of Wellington
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1
- Stages: Seed
- Focus: Health Care, Biotechnology, Medical Device

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Internet

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, SaaS, Information Technology

Right Click Capital - Australian Venture Capital Firm

## UniSA Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Health Care, Biotechnology

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

## Skip Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, SaaS

Skip Capital is a private investment fund investing in technology and infrastructure

## VU Venture Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Machine Learning

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

## Khosla Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Software, Artificial Intelligence, Health Care

Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.

## Fund WA
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Medical, Health Care, Manufacturing

FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Software, Artificial Intelligence

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Microsoft for Startups
- Type: VC Fund
- Location: Redmond, Washington, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.

## SOSV
- Type: VC Fund
- Location: Princeton, New Jersey, United States
- Relevant deals: 1
- Stages: Seed, Convertible Note, Pre-Seed
- Focus: Biotechnology, Health Care, Software

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

## Future of Healthcare Fund - Australian Unity
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Medical Device

A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians. 

## Monash Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Medical, Health Care, Biotechnology

Monash Ventures is a newly launched initiative from Monash University that serves as the university's dedicated venture and investment arm. Its purpose is to finance and nurture spinout companies, commercialise research outcomes—particularly in the healthcare sector—and support early-stage research commercialisation.

## SPRIM Global Investments
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Biotechnology, Health Care, Medical Device

SPRIM Global Investments is a privately held company established in 2008 after SPRIM Consulting & Services expanded globally.

## StreShi
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Bitcoin, FinTech, Medical

Progressive Technology To The People

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co